Stranded Technologies Podcast · Infinita City

Ep. 94: Jose Luis “Nintil” Ricón on Metascience, Longevity Biotech Pathways and Parallel Institutions

·1 hr 13 min·4 clips

OSKM reprogramming and FOXM1 are the two examples he treats as “sticky” rejuvenation.

He begins by explaining that he had been looking for advice to start his own company, and that the conversation with Joe McLacroix about Retro Biosciences became the path into Retro instead. That origin story quickly opens into a broader talk about being a generalist, writing, reading quickly, and what kind of background helps in a field that is still taking shape. The interview stays close to aging as the central problem. He lays out a framework that separates replacement, depletion, and rejuvenation, so the discussion has structure instead of just a string of anti-aging claims. Stem-cell turnover is one of the concrete examples. He describes the idea that tissue can be made younger by replenishing it with healthier cells, and he points to bone marrow transplantation as the kind of mechanism that shows how cells can be guided to where they are needed. The depletion pathway is different. In that version, you remove the most damaged or senescent cells so the remaining population is healthier on average and the system behaves differently over time. The third pathway is more local. Here the goal is to make the cells already in place work better, through ideas such as proper myosin or anything that boosts autophagy and preserves useful function. He also draws a sharp line between slowing aging and reversing it. Many interventions may slow decline, but only a small number should count as reversal, and even then the effect should be permanent or at least semi-permanent. That distinction matters because it keeps the conversation from blurring every helpful intervention into the same bucket. If the body simply returns to its prior state by tomorrow, the claim is weaker than it sounds. The episode keeps the listener oriented even when the biology gets dense. It does that by moving from broad definitions to specific examples and then back out to the bigger question of how frontier science gets organized. The larger show frame fits that pattern too. It treats technological acceleration as an institutional problem as much as a technical one, with regulation, startup cities, network states, and on-chain finance always lurking behind the science. Nintil’s blogging background gives the interview a reflective, reference-rich texture. By the end, the episode feels like a long argument about what it would take to make longevity research legible, testable, and genuinely transformative.

As heard by us

A technical, mechanism-first look at longevity biology and the limits of reversing aging.

The discussion suits listeners who want longevity biology handled at the mechanism level. Jose Luis de Gomez Hernandez de la Puente, known as Nintil, breaks aging into stem-cell turnover, depletion, and rejuvenation instead of flattening it into a slogan.

Read the full review in PlayNext →

Why you'd press play

If you want a serious take on longevity biotech from a show that frames frontier tech through regulation and institutions, press play.

Read the full recommendation in PlayNext →

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from Stranded Technologies Podcast